Integrum Feed

	Tid*
2025-06-03	07:00	Bokslutskommuniké 2025
2025-03-03	07:00	Kvartalsrapport 2025-Q3
2024-12-04	07:00	Kvartalsrapport 2025-Q2
2024-09-26	-	X-dag ordinarie utdelning INTEG B 0.00 SEK
2024-09-25	-	Årsstämma
2024-08-29	-	Kvartalsrapport 2025-Q1
2024-05-30	-	Bokslutskommuniké 2024
2024-02-29	-	Kvartalsrapport 2024-Q3
2023-12-04	-	Kvartalsrapport 2024-Q2
2023-10-04	-	X-dag ordinarie utdelning INTEG B 0.00 SEK
2023-09-27	-	Årsstämma
2023-08-31	-	Kvartalsrapport 2024-Q1
2023-06-08	-	Bokslutskommuniké 2023
2023-03-01	-	Kvartalsrapport 2023-Q3
2022-12-01	-	Kvartalsrapport 2023-Q2
2022-10-03	-	X-dag ordinarie utdelning INTEG B 0.00 SEK
2022-09-28	-	Årsstämma
2022-08-31	-	Kvartalsrapport 2023-Q1
2022-06-10	-	Bokslutskommuniké 2022
2022-03-02	-	Kvartalsrapport 2022-Q3
2021-12-02	-	Kvartalsrapport 2022-Q2
2021-09-09	-	X-dag ordinarie utdelning INTEG B 0.00 SEK
2021-09-02	-	Kvartalsrapport 2022-Q1
2021-05-31	-	Bokslutskommuniké 2021
2021-03-03	-	Kvartalsrapport 2021-Q3
2020-12-02	-	Kvartalsrapport 2021-Q2
2020-09-30	-	Årsstämma
2020-09-09	-	X-dag ordinarie utdelning INTEG B 0.00 SEK
2020-08-24	-	Kvartalsrapport 2021-Q1
2020-06-08	-	Bokslutskommuniké 2020
2020-04-20	-	Extra Bolagsstämma 2020
2020-03-02	-	Kvartalsrapport 2020-Q3
2019-12-02	-	Kvartalsrapport 2020-Q2
2019-09-30	-	Årsstämma
2019-09-25	-	X-dag ordinarie utdelning INTEG B 0.00 SEK
2019-09-02	-	Kvartalsrapport 2020-Q1
2019-06-10	-	Bokslutskommuniké 2019
2019-03-04	-	Kvartalsrapport 2019-Q3
2018-12-17	-	Kvartalsrapport 2019-Q2
2018-09-25	-	X-dag ordinarie utdelning INTEG B 0.00 SEK
2018-09-24	-	Årsstämma
2018-09-24	-	Kvartalsrapport 2019-Q1
2018-06-25	-	Bokslutskommuniké 2018
2018-03-26	-	Kvartalsrapport 2018-Q3
2017-12-18	-	Kvartalsrapport 2018-Q2
2017-09-25	-	Årsstämma
2017-09-25	-	Kvartalsrapport 2018-Q1
2017-06-30	-	Bokslutskommuniké 2017

Land	Sverige
Lista	First North Stockholm
Sektor	Hälsovård
Industri	Medicinteknik

2024-10-31 18:53:06 Integrum AB: Osseointegration for Amputees Makes its Education Forum Debut at OTA 2024 25,50 SEK | +0,39% | 0,14 MSEK

2024-10-07 15:02:45 Integrum AB: Ty Hanners utsedd till försäljningschef i USA med fokus på OPRA-implantatsystem för amputerade 27,10 SEK | +1,50% | 0,23 MSEK

2024-10-07 15:02:45 Integrum AB: Ty Hanners appointed Director of Sales, US, focused on OPRA Implant System for Amputees 27,10 SEK | +1,50% | 0,23 MSEK

2024-09-25 17:47:29 Årsstämmokommuniké - Integrum AB 27,20 SEK | -4,23% | 2,37 MSEK

2024-09-20 15:44:44 Integrum AB: Join Us for an Investor Update Online with our Acting CEO Scott Flora 27,70 SEK | -1,42% | 0,42 MSEK

2024-09-20 15:44:44 Integrum AB: Välkommen till investerarinformation online med vår nya tillförordnade VD Scott Flora 27,70 SEK | -1,42% | 0,42 MSEK

2024-09-17 17:55:48 Integrum AB: Inger Rydin is appointed interim COO and takes office immediately 28,00 SEK | -2,44% | 1,53 MSEK

2024-09-17 17:55:48 Integrum AB: Inger Rydin utses till interim COO och tillträder omedelbart 28,00 SEK | -2,44% | 1,53 MSEK

2024-09-15 22:28:18 Integrum AB: Styrelsen i Integrum utser Scott Flora till tillförordnad VD 28,70 SEK | -1,37% | 2,20 MSEK

2024-09-15 22:28:18 Integrum AB: The board of Integrum appoints Scott Flora as acting CEO 28,70 SEK | -1,37% | 2,20 MSEK

2024-09-04 16:59:20 Integrum AB: Integrum publicerar årsredovisning 2023/24 31,50 SEK | +4,30% | 2,44 MSEK

2024-08-29 07:00:00 Integrum AB: Fokus på långsiktig tillväxt leder till minskad omsättning 32,00 SEK | -37,98% | 41,9 MSEK

2024-08-29 07:00:00 Integrum AB: Focus on long-term growth creates setback in sales 32,00 SEK | -37,98% | 41,9 MSEK

2024-08-27 16:58:44 Kallelse till årsstämma i Integrum AB 51,60 SEK | -1,53% | 0,72 MSEK

2024-08-26 10:25:33 Integrum AB: Invitation to the First Quarter 2024/25 Results Presentation 52,40 SEK | +2,34% | 1,14 MSEK

2024-06-13 22:25:56 Integrum AB: Integrum has carried out a directed new issue of 961,539 series B shares, raising proceeds of approximately SEK 50 million 52,20 SEK | -5,43% | 13,1 MSEK

2024-06-13 22:25:56 Integrum AB: Integrum har genomfört en riktad nyemission om 961 539 B-aktier och tillförs cirka 50 miljoner kronor 52,20 SEK | -5,43% | 13,1 MSEK

2024-06-13 17:31:56 Integrum AB: Integrum intends to carry out a directed new issue of series B shares of approximately SEK 50 million 52,20 SEK | -5,43% | 13,1 MSEK

2024-06-13 17:31:56 Integrum AB: Integrum avser att genomföra en riktad nyemission av B-aktier om cirka 50 miljoner kronor 52,20 SEK | -5,43% | 13,1 MSEK

2024-06-13 08:36:08 Integrum AB: Integrum signs Memorandum of Understanding with Coapt for the use of its pattern recognition technology with the e-OPRA[TM] Implant System 55,20 SEK | -2,82% | 4,24 MSEK

2024-06-10 17:16:58 Integrum AB: Integrum enters collaboration and distribution agreement with Hanger - the leading provider of amputee care and prosthetics in the US 58,80 SEK | +7,30% | 2,27 MSEK

2024-05-30 07:00:00 Integrum AB: A Record Year in Sales 51,60 SEK | -6,86% | 9,77 MSEK

2024-05-30 07:00:00 Integrum AB: Ett år med rekordomsättning 51,60 SEK | -6,86% | 9,77 MSEK

2024-05-29 16:21:57 Integrum AB: Integrum receives market approval for OPRA[® in Israel] 55,40 SEK | +1,09% | 4,40 MSEK

2024-05-24 17:06:19 Integrum AB: Invitation to the Fourth Quarter 2023/24 Results Presentation 53,40 SEK | -0,37% | 1,41 MSEK

2024-05-15 07:00:00 Integrum AB: Integrum has been granted a registered trademark for OPRA® Implant System in the EU 57,00 SEK | +3,64% | 1,60 MSEK

2024-05-03 07:39:15 Integrum AB: Integrum launches short video documentary to showcase the company's efforts to treat combat amputees in Ukraine 55,40 SEK | -4,15% | 2,40 MSEK

2024-05-02 07:00:00 Integrum AB: Integrum expands its product offering to the United Kingdom market 57,80 SEK | +1,05% | 1,69 MSEK

2024-04-25 17:17:14 Integrum AB: Integrum kommenterar nedstängningen av Center for Bionics and Pain Research 51,40 SEK | -16,29% | 4,87 MSEK

2024-03-26 07:00:00 Integrum AB: Integrum expands its product offering into the Israeli market 50,40 SEK | +2,13% | 0,63 MSEK

2024-03-19 07:00:00 Integrum AB: Health economic study shows positive outcome using Integrum's OPRA[TM] Implant System over socket prostheses in transfemoral amputees 50,00 SEK | +12,36% | 2,07 MSEK

2024-03-18 16:06:08 Integrum AB: Integrums valberedning utsedd inför årsstämman 2024 44,50 SEK | -3,37% | 1,57 MSEK

2024-02-29 09:39:47 Integrum AB: Rättelse Ett nytt kvartal med rekordintäkter och 61 % tillväxt 48,00 SEK | +11,63% | 8,32 MSEK

2024-02-29 09:39:47 Integrum AB: CORRECTION A new record revenue quarter with 61% growth 48,00 SEK | +11,63% | 8,32 MSEK

2024-02-29 07:00:00 Integrum AB: A new record revenue quarter with 61% growth 48,00 SEK | +11,63% | 8,32 MSEK

2024-02-29 07:00:00 Integrum AB: Ett nytt kvartal med rekordintäkter och 61 % tillväxt 48,00 SEK | +11,63% | 8,32 MSEK

2024-02-23 09:26:07 Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation 39,50 SEK | +2,07% | 0,36 MSEK

2024-01-31 23:31:46 Integrum AB: Integrum has sold and delivered OPRA[TM] Implant Systems to a value of SEK 3.5 million to Center of Excellence in Ukraine 47,40 SEK | +6,28% | 1,37 MSEK

2023-12-20 08:41:06 Integrum AB: Integrum establishes Center of Excellence in Ukraine 43,00 SEK | -2,05% | 0,66 MSEK

2023-12-15 09:05:30 Integrum AB: Integrum's MDR certification is completed for the OPRA[TM] Implant System 41,50 SEK | +9,35% | 3,89 MSEK

2023-12-04 08:30:00 Integrum AB: Record sales and profitability 40,50 SEK | +1,25% | 2,86 MSEK

2023-12-04 08:30:00 Integrum AB: Rekordförsäljning och lönsamhet 40,50 SEK | +1,25% | 2,86 MSEK

2023-11-30 09:46:21 Integrum AB changes Certified Adviser to Carnegie Investment Bank AB (publ) 39,40 SEK | +1,03% | 1,01 MSEK

2023-11-28 11:45:00 Integrum AB: Invitation to the Second Quarter 2023/24 Results Presentation 39,05 SEK | -1,26% | 0,28 MSEK

2023-11-13 08:59:18 Integrum AB: Integrum plans to submit a PMA application to the FDA for the use of OPRA in transhumeral amputations based on existing clinical data 40,95 SEK | +12,65% | 4,33 MSEK

2023-11-10 16:50:02 Integrum AB: Correction missing MAR reference: Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023 36,35 SEK | +4,76% | 3,65 MSEK

2023-11-10 08:30:00 Integrum AB: Clinical study of Integrum's OPRA™ Implant System on below-knee amputations will include up to 30 patients and is fully funded by the Department of Defense 36,35 SEK | +4,76% | 3,65 MSEK

2023-11-09 09:05:31 Integrum AB: Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023 34,70 SEK | +28,76% | 5,16 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Integrum

Kalender

Beskrivning

Integrum

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden